PepGen Investor Relations Material
Latest events
Study Update
PepGen
Corporate Presentation
18 Jun, 2025
Q1 2025
8 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PepGen Inc
Access all reports
PepGen Inc. is a biotechnology company focused on developing nucleic acid-based therapies for neuromuscular and rare genetic diseases. The company specializes in peptide-conjugated oligonucleotide therapeutics designed to enhance drug delivery and effectiveness. Its research and development efforts target conditions such as Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1). The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for PepGen Inc
Corporate Presentation
PepGen Inc
24th Annual Needham Virtual Healthcare Conference
PepGen Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PEPG
Country
🇺🇸 United States